Literature DB >> 21896477

Exosite interactions impact matrix metalloproteinase collagen specificities.

Trista K Robichaud1, Bjorn Steffensen, Gregg B Fields.   

Abstract

Members of the matrix metalloproteinase (MMP) family selectively cleave collagens in vivo. However, the substrate structural determinants that facilitate interaction with specific MMPs are not well defined. We hypothesized that type I-III collagen sequences located N- or C-terminal to the physiological cleavage site mediate substrate selectivity among MMP-1, MMP-2, MMP-8, MMP-13, and MMP-14/membrane-type 1 (MT1)-MMP. The enzyme kinetics for hydrolysis of three fluorogenic triple-helical peptides (fTHPs) was evaluated herein. The first fTHP contained consensus residues 769-783 from type I-III collagens, the second inserted α1(II) collagen residues 763-768 N-terminal to the consensus sequence, and the third inserted α1(II) collagen residues 784-792 C-terminal to the consensus sequence. Our analyses showed that insertion of the C-terminal residues significantly increased k(cat)/K(m) and k(cat) for MMP-1. MMP-13 showed the opposite behavior with a decreased k(cat)/K(m) and k(cat) and a greatly improved K(m) in response to the C-terminal residues. Insertion of the N-terminal residues enhanced k(cat)/K(m) and k(cat) for MMP-8 and MT1-MMP. For MMP-2, the C-terminal residues enhanced K(m) and dramatically decreased k(cat), resulting in a decrease in the overall activity. These changes in activities and kinetic parameters represented the collagen preferences of MMP-8, MMP-13, and MT1-MMP well. Thus, interactions with secondary binding sites (exosites) helped direct the specificity of these enzymes. However, MMP-1 collagen preferences were not recapitulated by the fTHP studies. The preference of MMP-1 for type III collagen appears to be primarily based on the flexibility of the hydrolysis site of type III collagen compared with types I and II. Further characterization of exosite determinants that govern interactions of MMPs with collagenous substrates should aid the development of pharmacotherapeutics that target individual MMPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896477      PMCID: PMC3199499          DOI: 10.1074/jbc.M111.273391

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Matrix metalloproteinases as valid clinical targets.

Authors:  Barbara Fingleton
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Inhibitor fingerprinting of matrix metalloproteases using a combinatorial peptide hydroxamate library.

Authors:  Mahesh Uttamchandani; Jun Wang; Junqi Li; Mingyu Hu; Hongyan Sun; Kitty Y-T Chen; Kai Liu; Shao Q Yao
Journal:  J Am Chem Soc       Date:  2007-06-01       Impact factor: 15.419

Review 4.  Matrix metalloproteinase proteomics: substrates, targets, and therapy.

Authors:  Charlotte J Morrison; Georgina S Butler; David Rodríguez; Christopher M Overall
Journal:  Curr Opin Cell Biol       Date:  2009-07-16       Impact factor: 8.382

5.  NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices.

Authors:  Mark O Palmier; Yan G Fulcher; Rajagopalan Bhaskaran; Vinh Q Duong; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

6.  Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.

Authors:  Dmitriy Minond; Janelle L Lauer-Fields; Hideaki Nagase; Gregg B Fields
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

Review 7.  Collagens.

Authors:  Marion K Gordon; Rita A Hahn
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

8.  Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cells.

Authors:  Signe Ingvarsen; Daniel H Madsen; Thore Hillig; Leif R Lund; Kenn Holmbeck; Niels Behrendt; Lars H Engelholm
Journal:  Biol Chem       Date:  2008-07       Impact factor: 3.915

9.  Biochemical characterization of human collagenase-3.

Authors:  V Knäuper; C López-Otin; B Smith; G Knight; G Murphy
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

10.  Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation.

Authors:  R T Aimes; D L French; J P Quigley
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

View more
  25 in total

Review 1.  Biophysical studies of matrix metalloproteinase/triple-helix complexes.

Authors:  Gregg B Fields
Journal:  Adv Protein Chem Struct Biol       Date:  2014-11-07       Impact factor: 3.507

2.  Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases.

Authors:  Hsueh-Liang Fu; Anjum Sohail; Rajeshwari R Valiathan; Benjamin D Wasinski; Malika Kumarasiri; Kiran V Mahasenan; M Margarida Bernardo; Dorota Tokmina-Roszyk; Gregg B Fields; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

Review 3.  Interstitial collagen catabolism.

Authors:  Gregg B Fields
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Real-time tracking of single-molecule collagenase on native collagen and partially structured collagen-mimic substrates.

Authors:  James Froberg; Woo-Sik Choi; Abbas Sedigh; Tayebeh Anajafi; Jasmin Farmakes; Zhongyu Yang; Sanku Mallik; D K Srivastava; Yongki Choi
Journal:  Chem Commun (Camb)       Date:  2018-09-11       Impact factor: 6.222

5.  Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.

Authors:  Maciej J Stawikowski; Roma Stawikowska; Gregg B Fields
Journal:  Biochemistry       Date:  2015-05-05       Impact factor: 3.162

Review 6.  Chemical biology for understanding matrix metalloproteinase function.

Authors:  Anna Knapinska; Gregg B Fields
Journal:  Chembiochem       Date:  2012-08-30       Impact factor: 3.164

7.  Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.

Authors:  Manishabrata Bhowmick; Roma Stawikowska; Dorota Tokmina-Roszyk; Gregg B Fields
Journal:  Chembiochem       Date:  2015-03-12       Impact factor: 3.164

8.  The synthesis and application of Fmoc-Lys(5-Fam) building blocks.

Authors:  Michal Tokmina-Roszyk; Dorota Tokmina-Roszyk; Gregg B Fields
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

9.  The role of collagen charge clusters in the modulation of matrix metalloproteinase activity.

Authors:  Janelle L Lauer; Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Yan Lin; Steven R Van Doren; Gregg B Fields
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

10.  Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.

Authors:  Enrico A Stura; Robert Visse; Philippe Cuniasse; Vincent Dive; Hideaki Nagase
Journal:  FASEB J       Date:  2013-08-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.